1. Home
  2. CPSS vs PBYI Comparison

CPSS vs PBYI Comparison

Compare CPSS & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.38

Market Cap

191.4M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.82

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
PBYI
Founded
1991
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
263.4M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
CPSS
PBYI
Price
$9.38
$5.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
22.6K
389.6K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.87
EPS
0.80
0.74
Revenue
$196,531,000.00
$211,995,000.00
Revenue This Year
$139.62
N/A
Revenue Next Year
$10.58
N/A
P/E Ratio
$11.59
$7.80
Revenue Growth
6.67
N/A
52 Week Low
$6.67
$2.58
52 Week High
$12.73
$6.12

Technical Indicators

Market Signals
Indicator
CPSS
PBYI
Relative Strength Index (RSI) 66.09 67.11
Support Level $8.39 $4.84
Resistance Level $8.74 $5.11
Average True Range (ATR) 0.25 0.20
MACD 0.09 0.09
Stochastic Oscillator 80.69 99.01

Price Performance

Historical Comparison
CPSS
PBYI

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: